Novo Nordisk A/S

Healthcare · Drug Manufacturers - General

38.20$ -0.2% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Income Statement

Novo Nordisk A/S (NVO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 78,488 million DKK. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of DKK.

Tick rows to compare them in a chart (up to 4)

Income Statement NVO
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	27,537	29,572	28,452	28,638	26,614	27,992	26,930	27,407	27,762	29,732	29,291	30,036	30,277	32,417	33,875	30,006	30,927	32,138	33,804	33,041	35,622	38,333	42,031	41,265	45,566	48,092	53,367	54,300	58,731	65,863	65,349	68,060	71,311	85,683	78,087	76,857	74,976	79,144	96,823	78,488	329,431
Cost of Revenue	3,986	4,918	4,251	4,409	4,272	4,700	4,197	4,352	4,415	4,653	4,732	4,849	5,075	5,432	5,386	4,772	5,155	5,619	5,811	5,547	6,059	6,241	6,917	6,069	7,200	8,262	8,182	7,856	9,713	10,014	9,916	10,274	11,308	13,024	12,890	12,846	17,904	15,148	13,598	17,100	63,750
Gross Profit	23,551	24,654	24,201	24,229	22,342	23,292	22,733	23,055	23,347	25,079	24,559	25,187	25,202	26,985	28,489	25,234	25,772	26,519	27,993	27,494	29,563	32,092	35,114	35,196	38,366	39,830	45,185	46,444	49,018	55,849	55,433	57,786	60,003	72,659	65,197	64,011	57,072	63,996	83,225	61,388	265,681
Research & Development	3,458	4,470	3,289	3,414	3,328	3,983	3,321	3,296	3,644	4,544	2,678	3,557	3,601	4,384	3,777	3,291	3,911	4,483	3,944	3,944	4,252	5,632	5,206	5,123	5,633	8,085	6,728	7,127	8,128	10,460	8,606	16,166	9,488	13,802	10,308	11,690	15,393	14,648	10,284	17,787	58,112
Selling, General & Administrative	1,015	1,166	913	857	896	1,118	864	851	932	1,269	911	852	1,009	1,235	927	827	1,006	1,198	932	904	1,024	1,190	970	991	1,158	1,348	1,071	1,072	1,256	1,456	1,157	1,157	1,382	1,580	1,220	1,316	1,884	1,549	1,140	1,309	5,882
Total Operating Expenses	11,131	13,448	10,711	10,843	10,298	13,245	10,285	10,851	11,534	14,296	10,320	11,735	12,283	15,112	12,187	11,396	12,964	15,341	13,011	12,715	14,314	18,458	15,967	16,805	18,182	22,743	20,178	22,556	22,105	29,083	23,587	31,852	26,181	35,922	26,406	30,562	33,390	32,260	23,607	34,327	123,584
Operating Income	12,420	11,206	13,490	13,386	12,044	10,047	12,448	12,204	11,813	10,783	14,239	13,452	12,919	11,873	16,302	13,838	12,808	11,178	14,982	14,779	15,249	13,634	19,147	18,391	20,184	17,087	25,007	23,888	26,913	26,766	31,846	25,934	33,822	36,737	38,791	33,449	23,682	31,736	59,618	27,061	142,097
Interest Expense	119	264	744	1,164	26	1,792	37	745	675	886	1,030	1,322	829	794	1,298	519	279	513	797	–	927	781	1,438	3,252	3,725	731	1,122	281	2,168	916	2,074	1,562	821	5,093	5,183	4,958	5,007	8,630	3,499	1,500	18,636
Pre-Tax Income	12,301	10,942	13,004	12,643	12,462	10,571	13,609	12,498	11,138	10,370	13,222	12,145	12,107	11,079	15,021	13,416	12,691	12,002	15,938	14,917	15,112	13,113	17,919	16,795	18,032	16,316	24,737	24,254	28,063	27,620	31,918	25,332	34,384	35,557	37,033	33,805	25,517	34,185	62,172	26,875	148,749
Income Tax Expense	2,498	2,243	2,848	2,692	2,692	2,318	2,858	2,155	2,101	1,873	2,777	2,550	1,913	2,362	3,124	2,791	2,393	2,684	3,315	2,794	2,993	2,221	3,709	3,477	3,627	2,724	4,923	4,826	5,585	5,657	6,511	5,282	7,083	7,327	7,999	7,302	5,511	7,294	13,615	5,886	32,306
Net Income	9,803	8,699	10,156	9,951	9,770	8,253	10,751	10,343	9,037	8,497	10,445	9,595	10,194	8,717	11,897	10,625	10,298	9,318	12,623	12,123	12,119	10,892	14,210	13,318	14,405	13,592	19,814	19,428	22,478	21,963	25,407	20,050	27,301	28,230	29,034	26,503	20,006	26,891	48,557	20,989	116,443
EBITDA	13,156	11,640	14,456	14,670	12,750	9,684	14,378	14,011	12,596	10,718	15,310	14,577	15,031	9,516	17,405	15,093	15,100	11,675	18,112	16,134	17,388	13,808	21,007	21,683	23,798	9,505	27,578	26,712	32,756	28,511	36,906	35,739	37,355	45,848	46,046	43,596	33,274	39,747	69,207	38,679	180,907

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings